Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-06-02 LOSORDO DOUGLAS W Chief Medical Officer Grant or award · Stock Option (right to purchase) +33,750 33,750
2015-06-02 Preti Robert A See Remarks Grant or award · Stock Option (right to purchase) +33,750 0
2015-06-02 Wei Eric Director Grant or award +10,000 2,132,988
2015-06-02 Pecora Andrew L Director Grant or award +10,000 355,029
2015-06-02 TRABER PETER G Director Grant or award +10,000 10,000

Page 18 of 18 · 345 trades